Download PDF
Horm Metab Res 2015; 47(11): 833-838
DOI: 10.1055/s-0035-1555955
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Genetics of Apparently Sporadic Pheochromocytoma and Paraganglioma in a Chinese Population

C. H. Lee
1   Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
,
C. Y. Y. Cheung
1   Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
,
W. S. Chow
1   Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
,
Y. C. Woo
1   Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
,
C. Y. Yeung
1   Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
,
B. H. H. Lang
2   Department of Surgery, Queen Mary Hospital, Hong Kong SAR, China
,
C. H. Y. Fong
1   Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
,
K. H. M. Kwok
1   Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
,
S. P. L. Chen
3   Kowloon West Cluster Laboratory Genetic Service, Department of Pathology, Princess Margaret Hospital, Hong Kong SAR, China
,
C. M. Mak
3   Kowloon West Cluster Laboratory Genetic Service, Department of Pathology, Princess Margaret Hospital, Hong Kong SAR, China
,
K. C. B. Tan
1   Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
4   Research Centre of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
,
K. S. L. Lam
1   Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
4   Research Centre of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
› Author Affiliations
Further Information

Publication History

received 04 February 2015

accepted 01 July 2015

Publication Date:
12 August 2015 (online)

Also available at
    Permissions and Reprints

Abstract

Identification of germline mutation in patients with apparently sporadic pheochromocytomas and paragangliomas is crucial. Clinical indicators, which include young age, bilateral or multifocal, extra-adrenal, malignant, or recurrent tumors, predict the likelihood of harboring germline mutation in Caucasian subjects. However, data on the prevalence of germline mutation, as well as the applicability of these clinical indicators in Chinese, are lacking. We conducted a cross-sectional study at a single endocrine tertiary referral center in Hong Kong. Subjects with pheochromocytomas and paragangliomas were evaluated for the presence of germline mutations involving 10 susceptibility genes, which included NF1, RET, VHL, SDHA, SDHB, SDHC, SDHD, TMEM 127, MAX, and FH genes. Clinical indicators were assessed for their association with the presence of germline mutations. Germline mutations, 2 being novel, were found in 24.4% of the 41 Chinese subjects recruited and 11.4% among those with apparently sporadic presentation. The increasing number of the afore-mentioned clinical indicators significantly correlated with the likelihood of harboring germline mutation in one of the 10 susceptibility genes. (r=0.757, p=0.026). The presence of 2 or more clinical indicators should prompt genetic testing for germline mutations in Chinese subjects. In conclusion, our study confirmed that a significant proportion of Chinese subjects with apparently sporadic pheochromocytoma and paraganglioma harbored germline mutations and these clinical indicators identified from Caucasians series were also applicable in Chinese subjects. This information will be of clinical relevance in the design of appropriate genetic screening strategies in Chinese populations.

Key words

pheochromocytoma - paraganglioma - succinate dehydrogenase - multiple endocrine neoplasia
 

  • References

  • 1 Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young Jr WF, Endocrine S. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 1915-1942
    CrossrefPubMedSearch in Google Scholar
  • 2 Matro J, Giubellino A, Pacak K. Current and Future Therapeutic Approaches for Metastatic Pheochromocytoma and Paraganglioma: Focus on SDHB Tumors. Horm Metab Res 2013; 45: 147-153
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 2014; 14: 108-119
    CrossrefPubMedSearch in Google Scholar
  • 4 Brito JP, Asi N, Bancos I, Gionfriddo MR, Zeballos-Palacios CL, Leppin AL, Undavalli C, Wang Z, Domecq JP, Prustsky G, Elraiyah TA, Prokop LJ, Montori VM, Murad MH. Testing for germline mutations in sporadic pheochromocytoma/paraganglioma: a systematic review. Clin Endocrinol (Oxf) 2014; 82: 338-345
    PubMedSearch in Google Scholar
  • 5 Tong AL, Zeng ZP, Yang D, Li HZ, Li M. Clinical analysis of 25 patients with bilateral pheochromocytomas. Zhonghua Nei Ke Za Zhi 2005; 44: 751-754
    PubMedSearch in Google Scholar
  • 6 Sun HY, Cui B, Su DW, Jin XL, Sun FK, Zu Y, Jiang L, Wang WQ, Ning G. LOH on chromosome 11q, but not SDHD and Men1 mutations was frequently detectable in Chinese patients with pheochromocytoma and paraganglioma. Endocrine 2006; 30: 307-312
    CrossrefPubMedSearch in Google Scholar
  • 7 Zhang B, Wang YM, Wang N, Ha XQ, Dong YC, Zhou DH. Genetic detection and analysis of the VHL gene in patients with sporadic pheochromocytoma. Zhonghua Zhong Liu Za Zhi 2009; 31: 361-365
    PubMedSearch in Google Scholar
  • 8 Lo CY, Wat NM, Lam KY, Tiu SC, Chan J, Lam KS. Multiple endocrine neoplasia type 2A in Chinese families. Clin Endocrinol (Oxf) 2003; 58: 528
    CrossrefPubMedSearch in Google Scholar
  • 9 Qi XP, Chen XL, Ma JM, Du ZF, Fei J, Yang CP, Cheng J, Song QZ, Han JS, Jin HY, Chen ZG, Wang JQ, Yang YP, Ying RB, Liu WT, Zhao Y, Chen CY, Ke HP, Zhang XN. RET Proto-oncogene Genetic Screening of Families with Multiple Endocrine Neoplasia Type 2 Optimizes Diagnostic and Clinical Management in China. Thyroid 2012; 22: 1257-1265
    CrossrefPubMedSearch in Google Scholar
  • 10 Zheng X, Wei S, Yu Y, Xia T, Zhao J, Gao S, Li Y, Gao M. Genetic and clinical characteristics of head and neck paragangliomas in a Chinese population. Laryngoscope 2012; 122: 1761-1766
    CrossrefPubMedSearch in Google Scholar
  • 11 McInerney-Leo AM, Marshall MS, Gardiner B, Benn DE, McFarlane J, Robinson BG, Brown MA, Leo PJ, Clifton-Bligh RJ, Duncan EL. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas. Clin Endocrinol (Oxf) 2014; 80: 25-33
    CrossrefPubMedSearch in Google Scholar
  • 12 Toledo RA, Dahia PL. Next-generation sequencing for the genetic screening of phaeochromcytomas and paragangliomas: riding the new wave, but with caution. Clin Endocrinol (Oxf) 2014; 80: 23-24
    CrossrefPubMedSearch in Google Scholar
  • 13 Erlic Z, Rybicki L, Peczkowska M, Golcher H, Kann PH, Brauckhoff M, Mussig K, Muresan M, Schaffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plockinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz MK, Eng C, Neumann HP. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clin Cancer Res 2009; 15: 6378-6385
    CrossrefPubMedSearch in Google Scholar
  • 14 DeLellis RALR, Heitz PU, Eng C. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press; 2004
    Search in Google Scholar
  • 15 Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 2007; 3: 92-102
    CrossrefPubMedSearch in Google Scholar
  • 16 Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002; 346: 1459-1466
    CrossrefPubMedSearch in Google Scholar
  • 17 De Wailly P, Oragano L, Rade F, Beaulieu A, Arnault V, Levillain P, Kraimps JL. Malignant pheochromocytoma: new malignancy criteria. Langenbecks Arch Surg 2012; 397: 239-246
    CrossrefPubMedSearch in Google Scholar
  • 18 Neurofibromatosis . Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45: 575-578
    CrossrefPubMedSearch in Google Scholar
  • 19 Schulten HJ, Al-Maghrabi J, Al-Ghamdi K, Salama S, Al-Muhayawi S, Chaudhary A, Hamour O, Abuzenadah A, Gari M, Alqahtani M. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma. Anticancer Res 2011; 31: 4179-4183
    PubMedSearch in Google Scholar
  • 20 Da Silva AM, Maciel RM, Da Silva MR, Toledo SR, De Carvalho MB, Cerutti JM. A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 5438-5443
    CrossrefPubMedSearch in Google Scholar
  • 21 Ashida S, Okuda H, Chikazawa M, Tanimura M, Sugita O, Yamamoto Y, Nakamura S, Moriyama M, Shuin T. Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin Cancer Res 2000; 6: 3817-3822
    PubMedSearch in Google Scholar
  • 22 Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brackmann DE, Slattery 3rd WH, Myers EN, Ferrell RE, Rubinstein WS. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 2002; 39: 178-183
    CrossrefPubMedSearch in Google Scholar
  • 23 Burnichon N, Briere JJ, Libe R, Vescovo L, Riviere J, Tissier F, Jouanno E, Jeunemaitre X, Benit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez-Roqueplo AP. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010; 19: 3011-3020
    CrossrefPubMedSearch in Google Scholar
  • 24 Burnichon N, Cascon A, Schiavi F, Morales NP, Comino-Mendez I, Abermil N, Inglada-Perez L, de Cubas AA, Amar L, Barontini M, de Quiros SB, Bertherat J, Bignon YJ, Blok MJ, Bobisse S, Borrego S, Castellano M, Chanson P, Chiara MD, Corssmit EP, Giacche M, de Krijger RR, Ercolino T, Girerd X, Gomez-Garcia EB, Gomez-Grana A, Guilhem I, Hes FJ, Honrado E, Korpershoek E, Lenders JW, Leton R, Mensenkamp AR, Merlo A, Mori L, Murat A, Pierre P, Plouin PF, Prodanov T, Quesada-Charneco M, Qin N, Rapizzi E, Raymond V, Reisch N, Roncador G, Ruiz-Ferrer M, Schillo F, Stegmann AP, Suarez C, Taschin E, Timmers HJ, Tops CM, Urioste M, Beuschlein F, Pacak K, Mannelli M, Dahia PL, Opocher G, Eisenhofer G, Gimenez-Roqueplo AP, Robledo M. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res 2012; 18: 2828-2837
    CrossrefPubMedSearch in Google Scholar
  • 25 Castro-Vega LJ, Buffet A, De Cubas AA, Cascon A, Menara M, Khalifa E, Amar L, Azriel S, Bourdeau I, Chabre O, Curras-Freixes M, Franco-Vidal V, Guillaud-Bataille M, Simian C, Morin A, Leton R, Gomez-Grana A, Pollard PJ, Rustin P, Robledo M, Favier J, Gimenez-Roqueplo AP. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet 2014; 23: 2440-2446
    CrossrefPubMedSearch in Google Scholar
  • 26 Yao L, Schiavi F, Cascon A, Qin Y, Inglada-Perez L, King EE, Toledo RA, Ercolino T, Rapizzi E, Ricketts CJ, Mori L, Giacche M, Mendola A, Taschin E, Boaretto F, Loli P, Iacobone M, Rossi GP, Biondi B, Lima-Junior JV, Kater CE, Bex M, Vikkula M, Grossman AB, Gruber SB, Barontini M, Persu A, Castellano M, Toledo SP, Maher ER, Mannelli M, Opocher G, Robledo M, Dahia PL. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA 2010; 304: 2611-2619
    CrossrefPubMedSearch in Google Scholar
  • 27 Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 2015; Apr 6. pii: btv195 [Epub ahead of print]
    PubMedSearch in Google Scholar
  • 28 Wat NM, Lam TH, Janus ED, Lam KS. Central obesity predicts the worsening of glycemia in southern Chinese. Int J Obes Relat Metab Disord 2001; 25: 1789-1793
    CrossrefPubMedSearch in Google Scholar
  • 29 Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006; 163: 670-675
    CrossrefPubMedSearch in Google Scholar
  • 30 Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005; 23: 8812-8818
    CrossrefPubMedSearch in Google Scholar
  • 31 Mannelli M, Castellano M, Schiavi F, Filetti S, Giacche M, Mori L, Pignataro V, Bernini G, Giache V, Bacca A, Biondi B, Corona G, Di Trapani G, Grossrubatscher E, Reimondo G, Arnaldi G, Giacchetti G, Veglio F, Loli P, Colao A, Ambrosio MR, Terzolo M, Letizia C, Ercolino T, Opocher G. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 2009; 94: 1541-1547
    CrossrefPubMedSearch in Google Scholar
  • 32 Persu A, Lannoy N, Maiter D, Mendola A, Montigny P, Oriot P, Vinck W, Garin P, Hamoir M, Vikkula M. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update. Horm Metab Res 2012; 44: 349-353
    Thieme ConnectPubMedSearch in Google Scholar
  • 33 Benn DE, Robinson BG. Genetic basis of phaeochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab 2006; 20: 435-450
    CrossrefPubMedSearch in Google Scholar
  • 34 Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Mortality associated with phaeochromocytoma. Horm Metab Res 2013; 45: 154-158
    Thieme ConnectPubMedSearch in Google Scholar
  • 35 Genomes Project C . Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Hyun MK, Marth GT, McVean GA. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65
    Search in Google Scholar
  • 36 Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG, Gygi SP, Winge DR, Kremer H, Rutter J. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009; 325: 1139-1142
    CrossrefPubMedSearch in Google Scholar
  • 37 Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K. Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med 2012; 367: 922-930
    CrossrefPubMedSearch in Google Scholar
  • 38 Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, Pomeroy SL, Maris JM, Look AT, Meyerson M, Peeper DS, Carter BD, Kaelin Jr WG. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev 2008; 22: 884-893
    CrossrefPubMedSearch in Google Scholar
  • 39 Ladroue C, Carcenac R, Leporrier M, Gad S, Le Hello C, Galateau-Salle F, Feunteun J, Pouyssegur J, Richard S, Gardie B. PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med 2008; 359: 2685-2692
    CrossrefPubMedSearch in Google Scholar
  • 40 Welander J, Andreasson A, Juhlin CC, Wiseman RW, Backdahl M, Hoog A, Larsson C, Gimm O, Soderkvist P. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 2014; 99: E1352-E1360
    CrossrefPubMedSearch in Google Scholar